Citations 13

500 P2RX7 agonist treatment boosts the ability of IL-12-activated CD8+ T cells to infiltrate and control murine melanoma

Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A307.2-A308

10.1136/jitc-2020-sitc2020.0500

Different T Cell Receptor Signals Determine CD8 + Memory Versus Effector Development

Science | January 22, 2009 | Volume: 323 | Issue: 5913 | Pages: 502-505

10.1126/science.1163612 | PMID 19164748

Following infection, naïve CD8 + T cells bearing pathogen-specific T cell receptors (TCRs) differentiate into a mixed population of short-lived effector and long-lived memory T cells to mediate an adaptive immune response. How the TCR regulates memory T cell development has remained elusive. Using a mutant TCR transgenic model, we found that point mutations in the TCR β transmembrane domain (βTMD) impair the development and function of CD8 + memory T cells without affecting primary effector T cell responses. Mutant T cells are deficient in polarizing the TCR and in organizing the nuclear factor κB signal at the immunological synapse. Thus, effector and memory states of CD8 + T cells are separable fates, determined by differential TCR signaling.
Utility of membrane preconcentration-capillary electrophoresis-mass spectrometry in overcoming limited sample loading for analysis of biologically derived drug metabolites, peptides, and proteins

Journal of the American Society for Mass Spectrometry | July 25, 2002 | Volume: 8 | Issue: 1 | Pages: 15-24

10.1016/s1044-0305(96)00133-x